122 related articles for article (PubMed ID: 12116070)
1. Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes.
Luczynski W; Krawczuk-Rybak M; Muszynska-Roslan K; Stasiak-Barmuta A; Zak J
Med Pediatr Oncol; 2002 Aug; 39(2):147-8. PubMed ID: 12116070
[No Abstract] [Full Text] [Related]
2. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group.
Ek T; Mellander L; Andersson B; Abrahamsson J
Pediatr Blood Cancer; 2005 May; 44(5):461-8. PubMed ID: 15558707
[TBL] [Abstract][Full Text] [Related]
3. [Is cellular immunity not impaired after remission induction in acute lymphoblastic leukemia in children].
Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Kasprzycka E; Zak J; Nowakowska M
Pol Merkur Lekarski; 2004 Jan; 16(91):17-21. PubMed ID: 15080084
[TBL] [Abstract][Full Text] [Related]
4. [The treatment of acute lymphoblastic leukemias in adults].
Savchenko VG; Parovichnikova EN; Isaev VG; Kliasova GA; Kucher RA; Sokolov AN; Sarkisian GP; Gal'tseva IV; Ol'shanskaia IuV; Ustinova EN; Gribanova EO; Kokhno AV; Tikhonova LIu; Maslova ER
Ter Arkh; 1997; 69(7):5-11. PubMed ID: 9424759
[No Abstract] [Full Text] [Related]
5. Blinatumomab: a novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia.
Advani AS
Clin Adv Hematol Oncol; 2011 Oct; 9(10):776-7. PubMed ID: 22252580
[No Abstract] [Full Text] [Related]
6. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
Beck ID; Lemmel EM
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527
[No Abstract] [Full Text] [Related]
7. Biology and treatment of acute lymphoblastic leukemia.
Pieters R; Carroll WL
Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
[No Abstract] [Full Text] [Related]
9. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
10. [Th1/Th2 balance in acute lymphoblastic leukemia in children].
Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I; Matysiak M; Mitura-Lesiuk M; Kowalczyk J; Jeromin A
Przegl Lek; 2004; 61(9):919-23. PubMed ID: 15803899
[TBL] [Abstract][Full Text] [Related]
11. [Changes in blood lymphocytes and their subpopulation in patients with myeloblastic leukemia treated with cytostatic agents].
Urasiński I; Proniewska M; Schumacher K
Acta Haematol Pol; 1979; 10(2):129-36. PubMed ID: 314215
[TBL] [Abstract][Full Text] [Related]
12. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children.
Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I
Arch Immunol Ther Exp (Warsz); 2005; 53(4):357-63. PubMed ID: 16088321
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
14. T-lymphoblastic lymphoma/leukemia cells negative for CD52 and CD59.
Iwamoto N; Nagakura S; Kawaguchi T; Horikawa K; Takatsuki K; Nakakuma H
Int J Hematol; 1995 Jul; 62(1):55-7. PubMed ID: 7545456
[No Abstract] [Full Text] [Related]
15. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R
Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
[TBL] [Abstract][Full Text] [Related]
16. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
17. Decreased numbers of CD4+ T lymphocytes in peripheral blood after treatment of childhood acute lymphoblastic leukemia.
Mazur B; Szczepański T; Karpe J; Sońta-Jakimczyk D; Bubała H; Torbus M
Leuk Res; 2006 Jan; 30(1):33-6. PubMed ID: 16039713
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
19. Infant acute bilineal leukemia.
Derwich K; Sedek L; Meyer C; Pieczonka A; Dawidowska M; Gaworczyk A; Wachowiak J; Konatkowska B; Witt M; Marschalek R; Szczepański T
Leuk Res; 2009 Jul; 33(7):1005-8. PubMed ID: 19286255
[TBL] [Abstract][Full Text] [Related]
20. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
